Documente Academic
Documente Profesional
Documente Cultură
of Pharmacology
Drs. Admar Jas M.Sc. Apt
Senen, 17 Okt. 2011
INTRODUCTION OF PHARMACOLOGY
-Pharmacokinetic pharmacodymamic
-Homeostatic
PHARMACOLOGY DRUGS :
The study of substances that interact with living
systems:
1. Through chemical processes,
2. Especially by binding to regulatory molecules in
activating/ inhibiting normal body processes.
Pharmacokinetic (ADME)
Pharmacodynamic
-binding
-interaction with receptor or withouth receptor
-actions (activation / inhibiton)
Physics:
Physical
Solubility
Flammability
Explosivity
Stability (thermolability, Redoxybility)
Odourless, colourless, taste,
Koef. Partisi
Chemistry
Weak acid
Weak base
Oxydator
Reduktor
Note:
This is importan for absorption -- molecule across membrans cell
by transport, diffusion, filtrasi, vacuola etc.
DRUG SIZE.
Molecular size : MW 7 (lithium to over MW 50,000 (thrombolytic enzymes)
Molecular weight : 100 1000
The lower limit of this narrow range is probably set by the requirements for
spesificity of action.
To achieve sach selective binding, it appears that a molecule should in most
cases be at least 100 MW. The upper limit in molecular weight is determined
primarily by the requirement that drug be able to move within the body.
Drug larger than MW 1000 will not diffuse readly between compartement of the
body. Therefore, very large drugs (usually proteines) must be administered
directily into the compartement where they have their effect.
In the case of alteplase, a clor-dissolving enzyme, the drug is administered
directily into the vascular compartement by intravenous infusion.
Drug-Receptor
May be the Drug-receptor has bind chemical, sach as:
1. Van der waals
2. Ikatan hydrophob
3. Hydrogen
4. Ionic
5. Covalen
Ad. 1. Ikatan Van der waals,
gaya yg terjadi antara atom yg memp kemampuan polarisasi, kmd
terinduksi asimetrik dlm awan elektron oleh inti yg berdekatan letaknya shg
terjadi tarik menarik antara dua atom. Dayanya berkurang sebanding dg jarak
pangkat 6 --- 1/R 6.
Jarak antara atom, dimana gaya Van der Waals masih ada : 0,4-0,6 nm.
Ikatan yang terjadi antara muatan 2 ion yang berlawanan, interaksi elektrostatik sangat kuat, melebihi kekuatan
interaksi pada ikatan kovalen. Mis. : Na + + Cl- ------> NaCl
Mechanism
Bonds strength
hydrogen
++
ionic
+++
covalent
++++
2. Preventing the receptor to bind with its endogenous ligand, without changing the
conformation
Examples: Curare
3. Changes in receptor conformation
3.1. Enhancing the affinity of the drug for the receptor ------ inducet fit
receptor altering the action of the receptor.
Examples: insulin analog --- stimulate all the insulin receptor to the same extent
despite slightly different amino acid sequence
a) In the resting state, the and subunits of G protein are associated with one another,
and GDP is boud to subunit.
b) Binding of an extracellular ligand (agonist) to a G protein-coupled receptor exchange
of GTP for GDP on the subunit.
c) The subunit dissociates from the subunit, which diffuses to interact with effector
proteins. Interaction of the GTP-associated subunit with an effector activates the
effector.
o
o
o
3. Teori Charniere
Menerangkan mengapa suatu agonis, meskipun tdk dapat menggeser antagonis dari resep
tornya, dapat bersaing dg antagonis sesuai dengan hukum aksi masa. Reseptor mempunyai
dua kedudukan a. l:
1. Kedudukan kritis atau yang khas, yaitu berinteraksi dg ggs kromofor senyawa agonis.
2. Kedudukan non kritis atau tidak khas, yaitu membentuk kompleks dg ggs nonpolar
senyawa antagonis.
Menurut Chaniere, baik agonis maupun antagonis terikat pada kedudukan yg khas dg ikatan
lemah secara reversibel. Dsp itu antagonis juga terikat secara tidak khas melalui ikatan hidrofob
dan Van der Waals serta transfer muatan. Persaingan agonis dg antagonis terjadi pada kedu
dukan yg khas dg reseptor.
4. Inactivastion
Loss of ability a receptor to respond, to stimulation by a drug
5. Refractory
After a receptor is stimulated, a priod of time is required before the next drug-receptor
interaction can produce an effect.
Ad. V. Moleculler and celluler determinants of drug selectivity
Drug receptor interactions
Specificity : tissue, systems, organ where receptors are distributed (compartement)
Ex. Adrenergic and cholinergic
Selectivity : drug interacts preferentially on particular receptor types or sub types.
Ex. Propanolol: non selective ---- antagonist of 1 and 2
Atenolol : 1 selective, 2 less
Terbutalin : agonist of 2
Determinant :
The chemical structure may be very much different, yet the pharmacological action are similar.
A slight modification in chemical structuredoes not produce a dramatic chang in pharmacological
action. Structural specific drugs are those in which the pharmacological action dependent directly
on the chemical structure of the drug, wichh attaches itself to a three-dimensional structure of a
reseptor in the biophase. Prerequisites of the binding of a drug to receptor are: chemical, reactivity,
presence of fungsional groups, electonic distribution and topographic mirror-like image of the
receptor.
Stereoisomers
CH3
CH3
CH3
CH3
and
H
H
cis-1,4-Dimethylcyclohexane
trans
-1,4-Dimethylcyclohexane
Drugs similar pharmacological action have usually some common structural caracteristics
with functional groups in similar spatial direction. A slight modification in chemical
structure may produce dramatic change in pharmacological action (from incresed activity
to antagonism.
Receptor are all specific molecules, molecule complexes or part of these, which bind
the drug chemically and this complex exerts a pharmacological action.
Struktur spesifik, utk bekerja membutuhkan reseptor --- perubahan pada sistemefektor, ada efek dan
dapat diamati.
Struktur non spesifik, tidak butuh reseptor ---- tidak ada efek.
mis: Antacida, laksan osmotik / garam (MgSO4), gliserin, Na3 PO4
Diuretik osmotik